Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets
- PMID: 36836870
- PMCID: PMC9961552
- DOI: 10.3390/life13020513
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets
Abstract
Systemic sclerosis (SSc, or scleroderma) is a multifaceted rare connective tissue disease [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Varga J., Trojanowska M., Kuwana M. Pathogenesis of systemic sclerosis: Recent insights of molecular and cellular mechanisms and therapeutic opportunities. J. Scleroderma Relat. Disord. 2017;2:137–152. doi: 10.5301/jsrd.5000249. - DOI
Publication types
LinkOut - more resources
Full Text Sources
